Quantcast

Latest Anticonvulsants Stories

2014-06-17 08:26:35

Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from Upsher-Smith Laboratories, Inc.'s, Phase 3 study of USL255, Qudexy(TM) XR (topiramate) extended-release capsules, a proprietary, once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile, were published in the June issue of Epilepsia, a leading, authoritative...

2014-06-17 00:20:31

WOODCLIFF LAKE, N.J., June 16, 2014 /PRNewswire/ -- Eisai Inc. announced today that a Phase III clinical trial (study 332) of its in-house-discovered AMPA receptor antagonist perampanel has met its primary endpoint in patients with primary generalized tonic-clonic (PGTC) seizures, a severe form of seizures. http://photos.prnewswire.com/prnvar/20120413/MM87168LOGO Study 332 was a double-blind, randomized, placebo-controlled, multicenter, parallel-group trial to evaluate the efficacy and...

2014-04-25 08:27:40

WOODCLIFF LAKE, N.J., April 25, 2014 /PRNewswire/ -- Eisai Inc. announced today that six abstracts highlighting data analyses for FYCOMPA(TM) (perampanel) will be presented at the 66(th) annual American Academy of Neurology (AAN) meeting, taking place in Philadelphia, PA from April 26( )- May 3. http://photos.prnewswire.com/prnvar/20120413/MM87168LOGO "Eisai and its epilepsy franchise are committed to expanding its knowledge of current products and developing new medications for the...

2014-04-24 23:17:14

Flood Law Group announced today that they are available to investigate the claims of parents of children who suffer from birth defects that are possibly linked to the prescription drug Depakote. Flood Law Group always conducts a thorough investigation of a claim before taking on a case. Washington, D.C. (PRWEB) April 24, 2014 Flood Law Group today announced that they are now available to investigate the claims of parents of children who suffered from birth defects possibly as a result of...

Drug Treatment And Weight Loss Can Restore Vision Loss: Study
2014-04-23 12:11:19

NIH/National Eye Institute An inexpensive glaucoma drug, when added to a weight loss plan, can improve vision for women with a disorder called idiopathic intracranial hypertension (IIH), according to a study funded by the National Institutes of Health. IIH, also called pseudotumor cerebri, predominantly affects overweight women of reproductive age. An estimated 100,000 Americans have it, and the number is rising with the obesity epidemic. The most common symptoms are headaches and...

2014-04-23 09:37:13

In patients with idiopathic intracranial hypertension and mild vision loss, the use of the drug acetazolamide, along with a low-sodium weight-reduction diet, resulted in modest improvement in vision, compared with diet alone, according to a study in the April 23/30 issue of JAMA, a neurology theme issue. Idiopathic intracranial hypertension (IIH) is a disorder primarily of overweight women of childbearing age, characterized by increased intracranial pressure with its associated signs and...

2014-04-21 16:25:13

NEW YORK, April 21, 2014 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) announces a $190 Million settlement, subject to court approval, with Pfizer, Inc. and Warner-Lambert Co. ("Defendants") in In re Neurontin Antitrust Litigation, No. 02-1390, pending in the District of New Jersey. Kaplan Fox serves as one of two co-lead counsel representing a class of direct purchasers of Neurontin from Defendants between December 11, 2002 and August 31, 2008 and who...

2014-04-21 12:27:11

Upsher-Smith-sponsored data to include the first presentation of pooled Phase 1 data on the adverse event profile of USL255 (Qudexy(TM) XR (topiramate) extended-release capsules) MAPLE GROVE, Minn., April 21, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), will highlight new pooled phase 1 data from studies in healthy adults comparing the adverse event profile of USL255 (Qudexy(TM) XR) with immediate-release topiramate in a poster presentation at the 66(th) Annual Meeting...

2014-04-15 23:16:16

A pharmaceutical product liability litigation firm, Carey Danis & Lowe announced that they have launched an investigation into alleged Topamax related injuries following news that a Philadelphia court has settled 76 Topamax cases. St. Louis, Missouri (PRWEB) April 15, 2014 Carey Danis & Lowe has launched an investigation into alleged Topamax related injuries, specifically those pertaining to alleged congenital birth defects. The announcement of the law firm's investigation...

2014-04-02 23:30:03

Flood Law Group today announced that they are available to investigate claims of birth defects such as cleft palates or cleft lips that could be related to the use of the prescription drug Topamax during pregnancy. The FDA issued a Drug Safety Communication about use of topiramate (the generic version of Topamax) in 2011. Washington, D.C. (PRWEB) April 02, 2014 Flood Law Group announced today that they are now actively investigating claims on behalf of parents whose children were born...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related